Biomarkers PCA3 and TMPRSS2-ERG: better together

被引：0
|
作者：
机构：
来源：
Nature Reviews Urology | 2014年 / 11卷 / 3期
关键词：
D O I：
10.1038/nrurol.2014.38
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 129
相关论文
共 50 条
  • [31] URINE ASSAYS FOR PCA3 AND TMPRSS2:ERG GENE FUSION TO PREDICT THE DIAGNOSIS OF PROSTATE CANCER
    Silberstein, Jonathan
    Aubin, Sheila M. J.
    Weber, Art
    Christensen, Kimberly
    Kashefi, Carol
    Fradet, Yves
    Sakamoto, Kyoko
    JOURNAL OF UROLOGY, 2009, 181 (04): : 813 - 813
  • [32] Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis
    Robert, Gregoire
    Jannink, Sander
    Smit, Frank
    Aalders, Tilly
    Hessels, Daphne
    Cremers, Ruben
    Mulders, Peter F.
    Schalken, Jack A.
    PROSTATE, 2013, 73 (02): : 113 - 120
  • [33] TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
    Hagglof, Christina
    Hammarsten, Peter
    Stromvall, Kerstin
    Egevad, Lars
    Josefsson, Andreas
    Stattin, Par
    Granfors, Torvald
    Bergh, Anders
    PLOS ONE, 2014, 9 (02):
  • [34] Utility of PCA3 and TMPRSS2: ERG urinary biomarkers to predict pathologic outcomes in African American men undergoing radical prostatectomy.
    Feibus, Allison H.
    Sartor, Oliver
    Ledet, Elisa M.
    Shaw, Eric
    Moparty, Krishnarao
    Thomas, Raju
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [35] TMPRSS2-ERG Type VI Isoform Is Associated with a Higher Quantitative mRNA Expression of the TMPRSS2-ERG Rearrangement in Prostatic Adenocarcinoma
    Hernandez, S.
    Font, A.
    de Muga, S.
    Juanpere, N.
    Agell, L.
    Lorenzo, M.
    Lorente, J. A.
    Arango, O.
    Serrano, S.
    Lloreta, J.
    MODERN PATHOLOGY, 2014, 27 : 234A - 234A
  • [36] Cancer-associated Changes in the Expression of TMPRSS2-ERG, PCA3, and SPINK1 in Histologically Benign Tissue From Cancerous vs Noncancerous Prostatectomy Specimens
    Vaananen, Riina-Minna
    Lilja, Hans
    Kauko, Leni
    Helo, Pauliina
    Kekki, Henna
    Cronin, Angel M.
    Vickers, Andrew J.
    Nurmi, Martti
    Alanen, Kalle
    Bjartell, Anders
    Pettersson, Kim
    UROLOGY, 2014, 83 (02) : 511.e1 - 511.e7
  • [37] INDIVIDUALIZED PROSTATE CANCER RISK ASSESSMENT BY SERUM PSA, URINE TMPRSS2: ERG AND URINE PCA3
    Tomlins, Scott
    Wei, John
    Aubin, Sheila
    Meyer, Sarah
    Hodge, Petrea
    Aussie, Jacqueline
    Siddiqui, Javed
    Lonigro, Robert
    Day, John
    Groskopf, Jack
    Chinnaiyan, Arul
    JOURNAL OF UROLOGY, 2014, 191 (04): : E549 - E550
  • [38] TMPRSS2-ERG and PTEN loss in prostate cancer
    Jeremy A Squire
    Nature Genetics, 2009, 41 : 509 - 510
  • [39] Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
    Salami, Simpa S.
    Schmidt, Folke
    Laxman, Bharathi
    Regan, Meredith M.
    Rickman, David S.
    Scherr, Douglas
    Bueti, Gerardina
    Siddiqui, Javed
    Tomlins, Scott A.
    Wei, John T.
    Chinnaiyan, Arul M.
    Rubin, Mark A.
    Sanda, Martin G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (05) : 566 - 571
  • [40] TMPRSS2-ERG Type VI Isoform Is Associated with a Higher Quantitative mRNA Expression of the TMPRSS2-ERG Rearrangement in Prostatic Adenocarcinoma
    Hernandez, S.
    Font, A.
    de Muga, S.
    Juanpere, N.
    Agell, L.
    Lorenzo, M.
    Lorente, J. A.
    Arango, O.
    Serrano, S.
    Lloreta, J.
    LABORATORY INVESTIGATION, 2014, 94 : 234A - 234A
12345